Clinical Trials Browser

Terminated × Inflammatory Breast Neoplasms × Lapatinib × Clear all

NCT00756470 2014-11-17

Phase II Neoadjuvant in Inflammatory Breast Cancer

Phase 2 Terminated

15 enrolled 10 charts

Breast Neoplasms, Inflammatory Breast Neoplasms